-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Biocom reports: Recombinase polymerase amplification of RPA is known as a nucleic acid detection technology that can replace PCR .
More than 40 years have passed since mankind "declared war" on cancer, and this malignant disease is still a lingering shadow
RPA for cancer mutation detection
The Singapore A*STAR research team published in Lab on a Chip magazine last June , a new technology that can quickly detect single point mutations in cancer, Isothermal Solid Phase Amplification / Detection ( ISAD )
In this study, ISAD was mainly used to detect single point mutations in the HRAS ( Harvey RAS ) gene
Studies have shown that the sensitivity of ISAD technology is one hundred times higher than that of RPA and traditional PCR methods .
RPA is used for anti-cancer drug screening
Last October, a cancer study using RPA technology was also published in Talanta magazine .
An aptamer is a single-stranded short DNA .
The researchers optimized on the basis of BBC analysis, using Cyto-c specific aptamers, and replacing the time-consuming PCR with isothermal recombinase polymerase amplification ( RPA ) .
Biological Communication Editor: Ye Yu
